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SUMMARY
Formation of Bacillus subtilis biofilms, consisting of
cells encapsulated within an extracellular matrix of
exopolysaccharide and protein, requires the poly-
amine spermidine. A recent study reported that (1)
related polyamine norspermidine is synthesized by
B. subtilis using the equivalent of the Vibrio cholerae
biosynthetic pathway, (2) exogenous norspermidine
at 25 mM prevents B. subtilis biofilm formation, (3)
endogenous norspermidine is present in biofilms at
50–80 mM, and (4) norspermidine prevents biofilm
formation by condensing biofilm exopolysaccharide.
In contrast, we find that, at concentrations up to
200 mM, exogenous norspermidine promotes biofilm
formation. We find that norspermidine is absent in
wild-type B. subtilis biofilms at all stages, and higher
concentrations of exogenous norspermidine eventu-
ally inhibit planktonic growth and biofilm formation in
an exopolysaccharide-independent manner. More-
over, orthologs of the V. cholerae norspermidine
biosynthetic pathway are absent from B. subtilis,
confirming that norspermidine is not physiologically
relevant to biofilm function in this species.
INTRODUCTION
The ability of microbial cells to colonize a habitat is frequently
dependent on biofilm formation, a process by which microbial
cells form a sessile community encased in a self-produced
extracellular matrix (Costerton et al., 1995; Davey and O’Toole,
2000; Flemming and Wingender, 2010). This extracellular matrix
is typically composed of extracellular DNA, proteins, and exopo-
lysaccharides that together function to adhere cells to a surface
and provide protection from external physical and chemical
stresses (Branda et al., 2005; Flemming and Wingender, 2010).
To ensure correct deployment of these extracellular macromol-
ecules in Gram-positive and Gram-negative bacterial species,
biosynthesis is tightly regulated (Joo and Otto, 2012; Vlamakis
et al., 2013). The Gram-positive bacterium Bacillus subtilis has
emerged as a model organism for deciphering the molecular
basis of biofilm development (Vlamakis et al., 2013). Formation
of the extracellular matrix of B. subtilis biofilms is dependent
on production of an exopolysaccharide synthesized by the prod-
ucts of the epsA-O operon and an amyloid-like protein compo-
nent that is generated by products of the tapA-sipW-tasA operon
(Branda et al., 2006; Romero et al., 2010). Assembly of thematrix
also requires production of the bacterial hydrophobin BslA
that forms a hydrophobic coat over the biofilm surface (Hobley
et al., 2013; Kobayashi and Iwano, 2012; Ostrowski et al.,
2011). In the laboratory, biofilms formed by B. subtilis manifest
as robust surface-associated colonies and floating pellicles
that both display a complex rugose architecture (Branda et al.,
2001; Vlamakis et al., 2013).
Formation of robust colony biofilms and pellicles in B. subtilis
is dependent on the presence of the polyamine spermidine
(Burrell et al., 2010). Indeed, externally supplied spermidine
can restore biofilm formation to a B. subtilis spermidine auxo-
troph. In B. subtilis, the triamine spermidine is formed from the
diamine putrescine (Figure 1A) through transfer of an amino-
propyl group to putrescine by spermidine synthase encoded
by speE (Sekowska et al., 1998). The donor of the aminopropyl
group, decarboxylated S-adenosylmethionine, is produced by
the activity of S-adenosylmethionine decarboxylase, encoded
by speD (Figure 1A) (Sekowska et al., 2000). Putrescine and,
most likely, spermidine are required for biofilm formation in
Yersinia pestis, the causative agent of bubonic plague (Patel
et al., 2006; Wortham et al., 2010). However, for the cholera
agent Vibrio cholerae, biofilm formation is dependent on biosyn-
thesis of the unusual shorter structural analog of spermidine,
norspermidine (Figure 1B), and spermidine cannot replace the
function of norspermidine in biofilm formation in this species
(Lee et al., 2009). Furthermore, external norspermidine is sensed
by a substrate-binding protein homolog of a polyamine
transporter, which then stimulates biofilm formation (Karatan
et al., 2005; Karatan and Michael, 2013), whereas uptake of
844 Cell 156, 844–854, February 13, 2014 ª2014 The Authors
Open access under CC BY license.
exogenous spermidine inhibits biofilm formation (McGinnis et al.,
2009). The complete pathway for norspermidine biosynthesis
in V. cholerae (Figure 1B) has been established only recently
by Lee et al. (2009) and is enzymatically distinct from the spermi-
dine biosynthetic pathway found in B. subtilis. During planktonic
growth, spermidine is the only detectable polyamine inB. subtilis
(Burrell et al., 2010), whereas in V. cholerae, the only detectable
triamine is norspermidine (Lee et al., 2009).
Recently, a study reported thatB. subtilis synthesizes norsper-
midine in 8-day-old pellicle biofilms using the V. cholerae-type
biosynthetic pathway in order to disassemble the biofilm (Kolod-
kin-Gal et al., 2012). The authors reported thatB. subtilis biofilms
contain 50–80 mM norspermidine and that just 25 mM exogenous
norspermidine added to the growth medium prior to inocula-
tion fully inhibits biofilm formation without inhibiting planktonic
growth. It was proposed that the B. subtilis genes gabT and
yaaO encode the norspermidine biosynthetic enzymes L-2,4-dia-
minobutyrate:2-ketoglutarate 4-aminotransferase (DABA AT)
andcarboxynorspermidinedecarboxylase (CANSDC) (Figure1B),
respectively, and thatmutation of either of those genes abolished
norspermidine biosynthesis and prevented biofilm disassembly.
The authors also proposed that norspermidine inhibited biofilm
formation by binding to the exopolysaccharide. Due to the impor-
tant implications of these findings for understandingbiofilmphys-
iology and the biosynthesis and function of polyamines, our
laboratories each independently reexamined the key findings of
Kolodkin-Gal et al. (2012). In contrast, we find that norspermidine
is not synthesized byB. subtilis, is not naturally present in biofilms
formed byB. subtilis, and orthologs of the V. cholerae norspermi-
dine biosynthetic genes are absent from the B. subtilis genome.
Therefore, norspermidine is unlikely to have a native role in biofilm
physiology of this species, whereas the related polyamine sper-
midine is essential for robust biofilm formation.
RESULTS
Norspermidine Replaces the Essential Role of
Spermidine in B. subtilis Biofilm Formation
The polyamine spermidine (H2N(CH2)3NH(CH2)4NH2) (Figure 1A)
is essential for robust biofilm formation inB. subtilis (Burrell et al.,
2010). Deletion of the spermidine biosynthetic enzymes arginine
A B Figure 1. Spermidine and Norspermidine
Biosynthetic Pathways
(A) Spermidine biosynthetic pathway of B. subtilis
NCIB3610.
(B) Norspermidine biosynthetic pathway of
V. cholerae.
decarboxylase encoded by speA or S-
adenosylmethionine decarboxylase en-
coded by speD (Figure 1A) prevents
development of the highly wrinkled col-
ony biofilm morphology of the wild-type
B. subtilis strain NCIB3610 grown on
solid polyamine-free MSgg growth me-
dium (Figure 2A). Exogenous provision
of the shorter spermidine structural analog norspermidine
(H2N(CH2)3NH(CH2)3NH2) (Figure 1B) in the growth medium
is more effective than exogenous spermidine in restoring the
complex colony biofilm phenotype to the speA and speD spermi-
dine-deficient mutants, whereas the longer structural analog
homospermidine (H2N(CH2)4NH(CH2)4NH2) is ineffective at the
same concentrations (Figure 2A). Spermidine, norspermidine,
and homospermidine do not restore a normal complex colony
biofilm morphology to the tasA and eps mutants, which lack
the biofilm amyloid protein and exopolysaccharide, respectively.
Formation of robust pellicle biofilms of B. subtilis NCIB3610 that
develop at the liquid-air interface is also spermidine dependent
(Burrell et al., 2010). The wrinkled pellicle morphology of the
B. subtilis NCIB3610 wild-type strain is absent in the spermidine
biosynthetic mutants speA and speD (Figure 2B) after 2-day
incubation. Exogenous provision of just 5 mM spermidine or
norspermidine to the liquid MSgg growth medium at the start
of incubation restores the wrinkled pellicle morphology to the
speA and speDmutants, whereas homospermidine is ineffective
even at 100 mM (Figure 2B). Moreover, we noted that when exog-
enous norspermidine is provided to the B. subtilis wild-type
NCIB3610 strain at higher concentrations (25 or 100 mM) for
longer times (5 or 7 days), the pellicles become more wrinkled
(Figure 2C). This phenotype may not be as apparent if the
wild-type pellicle is already highly wrinkled. Increased wrinkling
occurred with a B. subtilis NCIB3610 isolate maintained by us
and also with an NCIB3610 isolate obtained from the Losick
laboratory (referred to here as NCIB3610-H) (Figure 2C).
Higher Concentrations of Norspermidine Eventually
Inhibit Planktonic Growth and Biofilm Formation
Given the essential role of spermidine in formation of B. subtilis
NCIB3610 robust colony and pellicle biofilms and the ability of
norspermidine to efficiently substitute for spermidine in this func-
tion, we were surprised by the finding of Kolodkin-Gal et al.
(2012) that norspermidine at a concentration of only 25 mM
prevents formation of B. subtilis NCIB3610 pellicle biofilms.
Our two laboratories each independently assayed the effect
of exogenously supplied norspermidine on pellicle formation.
In contrast to the finding of Kolodkin-Gal et al. (2012) that
B. subtilis NCIB3610 pellicle biofilm formation is inhibited by
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25 mM norspermidine, we found that biofilm formation was
not inhibited until a concentration of 250 mM norspermidine
(Figure 3A). We were concerned that our laboratory isolate of
B. subtilis NCIB3610 might differ in behavior toward exoge-
nously provided norspermidine compared with the NCIB3610-
H isolate used by Kolodkin-Gal et al. (2012). However, analysis
demonstrated that the two isolates behaved very similarly, with
pellicle formation being prevented by a concentration of exoge-
nous norspermidine of between 250 and 300 mM (Figure 3A).
It was noted by Kolodkin-Gal et al. (2012) that the wispy
fragments of floating material present in an exopolysaccharide
mutant were unaffected by addition of norspermidine at
the same concentrations that inhibited pellicle formation of
B. subtilis NCIB3610. They postulated that norspermidine in-
hibited biofilm formation by interfering with the exopolysacchar-
ide component of the biofilmmatrix. In contrast, we found that at
a concentration of 300 mM norspermidine, the wispy fragments
of floating material in the exopolysaccharide mutant eps (A-O)
strain no longer formed, and at 500 mM norspermidine, no resid-
ual pellicle material could be detected with the B. subtilis
NCIB3610 eps (A-O) mutant (Figure 3B). These results sug-
gested to us that norspermidine might be inhibiting the growth
of planktonic cells, which in turn would lead to the biofilm defects
observed. Therefore, the effect of increasing concentrations of
norspermidine on planktonic growth ofB. subtilisNCIB3610 (Fig-
ures 3C and 3E) and the eps (A-O) exopolysaccharide mutant
(Figures 3D and 3F) was examined. A concentration of 300 mM
norspermidine had a marked inhibitory effect on growth in both
strains, and a concentration of 1 mM norspermidine essentially
abolished growth of both strains (Figures 3C and 3D). There
was little effect on planktonic growth in the presence of 1 mM
spermidine (Figures 3E and 3F).
Norspermidine Is Not Present in B. subtilis Pellicle
Biofilms
The concentration of norspermidine in 8-day-old pellicles deter-
mined by Kolodkin-Gal et al. (2012) was 50–80 mM, but the pres-
ence of spermidine was not reported. To determine whether
spermidine was also present in the pellicles, we employed
high-performance liquid chromatography (HPLC) with pure
chemical standards to both detect and distinguish spermidine
and norspermidine. Two different labeling methods were used
to detect the polyamines, by attaching chemical tags that would
then render them visible by fluorescence detection. The first
approach used a commercial amino acid detection system
(AccQ-Fluor Reagent; Waters) that derivatizes polyamines with
the fluorescent AccQ-Fluor tag (Figure 4), whereas the second
approach derivatized polyamines by dansylation (Figure 5).
Analysis of 3-day-old and 8-day-old B. subtilis NCIB3610 pel-
licles grown in polyamine-free MSggmedium indicated the pres-
ence of spermidine but the complete absence of norspermidine
(red traces in Figures 4A and 4C). As expected, the spermidine
peak was absent in residual pellicle samples derived from the
spermidine biosynthetic mutants speA and speD (Figures 4D
and 4F). The absence of norspermidine in 8-day-old pellicles
was surprising given the finding of Kolodkin-Gal et al. (2012)
that norspermidine was present at 50–80 mM. To exclude the
possibility that our HPLC systemwas unable to detect a norsper-
midine concentration of 50–80 mM, we determined the limit of
detection of a pure norspermidine standard added to the
B. subtilis NCIB3610 pellicle material before extraction with tri-
chloroacetic acid. The limit of norspermidine detection from
the pellicle material was found to be well below 0.5 mM (Fig-
ure 4E). To confirm that self-produced norspermidine could be
detected by our analytical system, cells of Vibrio parahaemolyti-
cus, which encodes a norspermidine biosynthetic pathway
highly similar to that of V. cholerae, were analyzed and found
to contain norspermidine (Figure 4B) and some spermidine.
The spermidine was likely derived from the Luria Bertani (LB)
growth medium used to grow the V. parahaemolyticus, whereas
LB medium does not contain norspermidine (McGinnis et al.,
2009). As an alternative fluorescence-derivatization approach
for labeling polyamines with a fluorescent chemical tag, pellicle
extracts were dansylated and then analyzed by HPLC. Analysis
Figure 2. Norspermidine Replaces the
Function of Spermidine in BiofilmFormation
(A) Complex colony biofilms of B. subtilis strains
were grown on solid MSgg medium with or
without polyamines indicated. MSgg, polyamine-
free chemicallydefined growth medium; Spd,
spermidine; Nspd, norspermidine; Hspd, homo-
spermidine. Strains of B. subtilis included
NCIB3610 (wild-type strain), tasA (mutant of the
biofilm amyloid protein [NRS2415]), eps(A-O)
(mutant of the exopolysaccharide biosynthetic
gene cluster [NRS2450]), speA (mutant of argi-
nine decarboxylase [putrescine and spermidine
auxotroph, NRS3089]), and speD (mutant of
S-adenosylmethionine decarboxylase [spermi-
dine auxotroph, NRS4005]). Strains were grown
at 30C for 48 hr prior to imaging. Scale bars
represent 2.5 mm.
(B) Pellicle biofilms of B. subtilis strains formed
at the liquid-air interface on liquid growth
medium after 2 days of incubation at 25C. Strains of B. subtilis included NCIB3610, eps(A-O), speA, and speD.
(C) Norspermidine promotes B. subtilis wild-type pellicle biofilm formation and rugosity. Cells of our laboratory B. subtilis wild-type isolate (NCIB3610) and the
wild-type isolate from the Losick laboratory (NCIB3610-H) were grown for either 5 or 7 days in MSgg liquid medium with 0, 25, or 100 mM norspermidine.
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of 1-, 3-, and 8-day-old pellicles indicated the presence of sper-
midine increasing in concentration from day 1 to day 3 and then
declining by day 8 (Figures 5A–5C). Norspermidine was not
detected at any stage of pellicle development in the NCIB3610
strain, and spermidine was absent in the speA strain from the
corresponding stages (Figures 5D–5F). Pure norspermidine
and spermidine chemical standards were easily resolved by
the solvent system (Figures 5G–5I). With the dansylationmethod,
the limit of detection for norspermidine was below 0.3 mM.
B. subtilis Lacks a Norspermidine Biosynthetic Pathway
Given our finding of a complete absence of detectable nor-
spermidine in B. subtilis NCIB3610 pellicles of various ages,
determined independently in each of our laboratories, and the
obvious discrepancy with the findings of Kolodkin-Gal et al.
(2012), we analyzed the genome of B. subtilis for the presence
of norspermidine biosynthetic genes. The first step in the
Figure 3. Higher Concentrations of
Norspermidine Inhibit Growth and Pellicle
Formation
(A) Effect of higher norspermidine concentrations
on wild-type pellicle formation. Cells of our labo-
ratory B. subtilis NCIB3610 isolate (3610) or an
isolate from the Losick laboratory (3610-H) were
grown for 2 days in increasing concentrations of
norspermidine in liquid MSgg medium.
(B) Norspermidine inhibits the formation of the
vestigial pellicle fragmentsof an exopolysaccharide
mutant. NCIB3610, wild-type B. subtilis; eps(A-O)
(NRS2450), exopolysaccharide-deficient mutant.
(C) Norspermidine inhibits the growth of B. subtilis
NCIB3610 planktonic cells. Growth of B. subtilis
NCIB3610 planktonic cells grown in liquid MSgg
at 37C with shaking at different concentrations of
norspermidine is shown.
(D) Norspermidine inhibits the growth of B. subtilis
eps(A-O) exopolysaccharide-deficient planktonic
cells. Growth of B. subtilis eps(A-O) (NRS2450)
planktonic cells grown in liquid MSgg at 37C
with different concentrations of norspermidine is
shown.
(E) Norspermidine but not spermidine inhibits the
growth of B. subtilis NCIB3610 planktonic cells.
Growth of B. subtilis NCIB3610 planktonic cells
grown in liquid MSgg at 37C with shaking and
no polyamine, 1 mM norspermidine (repeated
from C), or 1 mM spermidine is shown.
(F) Norspermidine but not spermidine inhibits the
growth of B. subtilis eps(A-O) exopolysaccharide-
deficient planktonic cells. Growth of B. subtilis
eps(A-O) planktonic cells grown in liquid MSgg
at 37C with shaking and no polyamine, 1 mM
norspermidine (repeated from D), or 1 mM sper-
midine is shown.
V. cholerae norspermidine biosynthetic
pathway is conversion of aspartate
b-semialdehyde to 2,4-diaminobutyrate
(Ikai and Yamamoto, 1997), catalyzed
by the enzyme DABA AT (EC.2.6.1.76).
Kolodkin-Gal et al. (2012) asserted that norspermidine is syn-
thesized in B. subtilis via the same pathway employed in
V. cholerae (Lee et al., 2009), and they selected gabT as the
orthologous gene encoding DABA AT. They concluded that
the gabT mutant strain was blocked in norspermidine produc-
tion. This result is surprising because previously published
data demonstrated that gabT encodes the enzyme 4-aminobu-
tyrate:2-ketoglutarate aminotransferase (EC.2.6.1.19) that is
involved in 4-aminobutyrate (GABA) catabolism (Dover and
Halpern, 1974). Another study showed that in the B. subtilis
strain SMY, mutation of the gabT gene prevented utilization of
GABA as a sole nitrogen source (Belitsky and Sonenshein,
2002). Here, we constructed an in-frame mutant of gabT in
the B. subtilis NCIB3610 strain (Figure 6A) and confirmed
a loss of growth on GABA as the sole nitrogen source (Fig-
ure 6C). Complementation of the B. subtilis NCIB3610
gabT mutant with the native gabT gene under control of the
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isopropyl b-D-1-thiogalactopyranoside (IPTG)-inducible pro-
moter (Phy-spank) restored growth on GABA as the sole nitrogen
source in the presence of IPTG (Figure 6D). Consistent with
these findings, catabolism of GABA by GabT produces succi-
nate semialdehyde, which is converted to succinate by succi-
nate semialdehyde dehydrogenase (GabD). In B. subtilis, the
gabT gene is found immediately upstream of gabD in a GABA
catabolic operon (Figure 6A). Differences between the DABA
AT reaction required for synthesis of 1,3-diaminopropane and
norspermidine and the GabT reaction required for catabolism
of 4-aminobutyric acid (GABA) are shown in Figure 6F. The
key difference is that the product of GabT is succinate semialde-
hyde, which is converted by GabD to succinate for entry into the
tricarboxylic acid cycle, whereas the product of DABA AT is the
amino acid L-2,4-diaminobutyrate, which is then committed to
polyamine biosynthesis by the action of L-2,4-diaminobutyrate
decarboxylase (DABA DC).
The B. subtilis NCIB3610 genome contains several genes en-
coding proteins with some similarity to V. cholerae DABA AT, all
of which belong to the aspartate aminotransferase family
(Schneider et al., 2000). Most similar are argD encoding N-ace-
tylornithine aminotransferase (34% aa identity), rocD encoding
ornithine aminotransferase (30% aa identity), and as discussed
above, gabT (30% aa identity). The Gram-positive B. subtilis
GabT protein is more similar to GabT encoded by the Gram-
negative Acinetobacter baumannii than to DABA AT from related
Bacillus megaterium (Figure S1A available online). Furthermore,
the B. subtilis, B. megaterium, and A. baumannii gabT open
reading frame (ORF) is found clustered with a gabD ORF,
whereas the DABA AT-encoding ORF from A. baumannii,
B. megaterium, and V. cholerae is found adjacent or fused to a
DABA DC-encoding ORF (Figure S1B). Thus, confirmed enzy-
matic activity (Belitsky and Sonenshein, 2002), sequence similar-
ity, and operon context demonstrate that the B. subtilis GabT is
involved in GABA catabolism and not biosynthesis of norspermi-
dine. The next step in the V. cholerae norspermidine biosynthetic
pathway is the conversion of L-2,4-diaminobutyrate produced
by DABA AT to 1,3-diaminopropane, accomplished by DABA
DC (EC.4.1.1.68). Sequence analysis indicates that there are
no homologs of DABA DC in any sequenced B. subtilis genome
except for a distant homolog (YP_005559741) encoded in
B. subtilis subspecies Natto BEST195; however, this genome
does not encode DABA AT. In conclusion, B. subtilis does not
encode the biosynthetic pathway for the norspermidine precur-
sor 1,3-diaminopropane.
After conversion of L-2,4-diaminobutyrate to 1,3-diaminopro-
pane, the next step in norspermidine production in V. cholerae is
conversion of 1,3-diaminopropane to carboxynorspermidine by
the enzyme carboxynorspermidine dehydrogenase (CANSDH)
(Figure 1B). We find that no homologous gene is present in
any sequenced B. subtilis genome. Carboxynorspermidine is
then converted to norspermidine by CANSDC. Kolodkin-Gal
et al. (2012) selected the yaaO gene as the B. subtilis ortholog
of CANSDC and found that a yaaO mutant strain produced
a longer-lasting pellicle. However, our protein sequence com-
parison analysis (Figure 7) indicates that YaaO exhibits negli-
gible sequence similarity with the biochemically characterized
CANSDC proteins from V. cholerae and Campylobacter jejuni.
A B
C D
E F
Figure 4. Norspermidine Is Not Present in B. subtilis NCIB3610
Pellicle Biofilms
HPLC analysis of polyamine content of pellicles. R, AccQ-Fluor reagent; IS,
internal standard (1,7-diaminoheptane). Red trace indicates pellicle material,
and black trace indicates pellicle material spiked with norspermidine standard
before extraction with perchloric acid (except in E; see specific legend). The
position of spermidine was confirmed by spiking a separate pellicle sample
with pure spermidine standard (data not shown).
(A) Polyamines detected by HPLC analysis of wild-typeB. subtilisNCIB3610 3-
day-old pellicles grown in liquid MSgg medium. Representative analysis of
three independent experiments is presented.
(B) Endogenous norspermidine detected by HPLC analysis of
V. parahaemolyticus RIMD 2210633. Cells of V. parahaemolyticus RIMD
2210633 were grown in MLB liquid growth medium.
(C) Polyamines detected byHPLC analysis of wild-typeB. subtilisNCIB3610 8-
day-old pellicles grown in MSgg medium. Representative analysis of three
independent experiments is presented.
(D) Polyamines detected by HPLC analysis of B. subtilis speA (NRS3089)
8-day-old pellicles grown in MSgg medium. Representative analysis of three
independent experiments is shown.
(E) Limit of detection of norspermidine in 8-day-old pellicles of B. subtilis
NCIB3610. Different concentrations of pure norspermidine standard were
spiked into 8-day-old pellicles before extraction of polyamines from the pel-
licles with trichloroacetic acid. The wild-type trace with no added norspermi-
dine is colored black.
(F) Polyamines detected by HPLC analysis of B. subtilis speD (NRS4005)
8-day-old pellicles grown in MSgg medium. Representative analysis of three
independent experiments is presented.
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Instead, YaaO is a homolog of the B. subtilis SpeA
(YP_007533417) biosynthetic arginine decarboxylase (34.9%
aa identity in 467 aa overlap) and the E. coli AdiA acid-inducible
arginine decarboxylase protein (Burrell et al., 2010) and is there-
fore from a different protein fold to CANSDC (Deng et al., 2010).
In short, genes encoding CANSDH and CANSDC are absent
from all B. subtilis genomes. An endogenous plasmid, pBS32
is present in B. subtilis NCIB3610 (Konkol et al., 2013), but
DABA AT, DABA DC, CANSDH, and CANSDC are not encoded
on this plasmid. Finally, we resequenced the genomes of the
two isolates of B. subtilis used in our experiments (NCIB3610
and NCIB3610-H) and compared them with the reference
genome of B. subtilis 168 (Srivatsan et al., 2008). There are 29
SNPs unique to the isolate of B. subtilis NCIB3610 from our lab-
oratory and 28 SNPs unique to theB. subtilisNCIB3610-H isolate
(Table S1). None of the SNPs in either NCIB3610 isolate affects
any genes related to polyamine metabolism.
DISCUSSION
The biosynthesis of norspermidine in V. cholerae is achieved by
four different enzymatic steps that have been biochemically
characterized and the corresponding V. cholerae genes identi-
fied (Ikai and Yamamoto, 1994, 1997; Lee et al., 2009; Nakao
et al., 1991; Yamamoto et al., 1986). Based on our comparative
genomic analyses described above, it is clear that there are no
homologs of DABA DC, CANSDH, or CANSDC in B. subtilis
NCIB3610. Distant homologs of DABA AT are present, but they
have known functions and are not involved in norspermidine
biosynthesis: argD encodingN-acetylornithine aminotransferase
(Mountain et al., 1986), rocD encoding ornithine aminotrans-
ferase (Gardan et al., 1995), and gabT encoding GABA amino-
transferase (Belitsky and Sonenshein, 2002). Thus, the claim
by Kolodkin-Gal et al. (2012) that the genes gabT and yaaO
encode orthologs of V. cholerae DABA AT and CANSDC is
Figure 5. Spermidine Is Present at All Stages of B. subtilis Pellicle Biofilm Development
Polyamines were detected by HPLC after derivatization with dansyl chloride.
(A–C) Polyamine content in wild-type B. subtilis NCIB3610 pellicle biofilms at days 1, 3, and 8 of development, respectively.
(D–F) Polyamine content in pellicles of the B. subtilis speA polyamine auxotrophic mutant at days 1, 3, and 8 of development, respectively.
(G–I) Pure spermidine, norspermidine, and combined spermidine and norspermidine chemical standards, respectively.
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erroneous. Not only does YaaO exhibit no homology to CANSDC
(Figure 7), but B. subtilis gabT has been shown previously to be
essential for GABA catabolism (Belitsky and Sonenshein, 2002).
We cannot explain the discrepancies between our findings
and those of Kolodkin-Gal et al. (2012), although we note that
the mass spectrometric analysis of norspermidine presented
by those authors was that of a pure norspermidine chemical
standard from Sigma-Aldrich and not of a biological sample
(Figure S1 of Kolodkin-Gal et al., 2012). Indeed, the only data
presented that examined the presence of norspermidine within
a biological sample are the liquid chromatography-mass spec-
trometry (LC-MS) analysis of pellicle material presented in their
Figure 1C, which presents only retention times and not mass
analysis. Moreover, it should be noted that this figure does not
include a control pellicle sample spiked with a pure norspermi-
dine standard to indicate where the norspermidine elutes after
extraction from the biological matrix. In the absence of any other
supporting evidence, it is not clear why it was concluded by
Kolodkin-Gal et al. (2012) that norspermidine was present in
the pellicle material. It is also unclear why spermidine was
not detected because it is abundant in pellicles at all develop-
mental stages and elutes from an LC column very close to
norspermidine.
To ascertain the level of norspermidine in the B. subtilis 8-day-
old pellicles, our two laboratories independently attempted to
detect norspermidine at various stages of pellicle development.
At physiological pH, the amine groups of polyamines such as
norspermidine are fully protonated and bind strongly to polya-
nionic molecules. To extract all noncovalently bound polyamines
frompellicles, we used an aggressive extraction procedure using
trichloroacetic acid (CCl3COOH). We note that Kolodkin-Gal
et al. (2012) used PBS to extract polyamines, whichmay account
for the lack of detection of spermidine. Nevertheless, we did
not detect any norspermidine in 8-day-old pellicles or in pelli-
cles at any stage, although our limit of detection was below
0.5 mM, i.e., less than 1% of the concentration reported by
Kolodkin-Gal et al. (2012). In contrast, we found that spermi-
dine was abundant at all stages of pellicle development but
decreased with increasing age of the pellicle (Figures 4 and 5).
Furthermore, we found that norspermidine detection from cells
of V. parahaemolyticus, which possesses the norspermidine
biosynthetic pathway, was facile (Figure 4B).
We determined that the concentration of norspermidine that
inhibited pellicle formation (250 mM) was ten times higher than
that reported by Kolodkin-Gal et al. (2012). Those authors
suggested that norspermidine triggers biofilm disassembly by
Figure 6. GabT Is Involved in GABA Catabolism and Not Biosyn-
thesis of Norspermidine
(A) Schematic of the B. subtilis GABA catabolic operon. The transcription
factor-encoding gabR ORF is transcribed divergently from the gabT and gabD
ORFs. Arrows and filled circles represent transcriptional promoters and
terminators, respectively.
(B) Schematic of the arrangement of B. subtilis strains grown on solid MSgg
growthmediumplates. Top-left view shows thewild-typeB. subtilisNCIB3610,
top-right view shows B. subtilis gabT mutant (NRS4007), and bottom view
shows B. subtilis gabT mutant expressing an IPTG-inducible wild-type gabT
ORF from the heterologous amyE site on the chromosome (NRS4104).
(C) The B. subtilis strains detailed above grown on MS medium containing
0.5% GABA as the sole nitrogen source and 0.5% glycerol as the carbon
source.
(D) Strains detailed above grown on MS medium containing 0.5% GABA as
the sole nitrogen source, with induction of the complimenting gabT gene by
50 mM IPTG.
(E) Strains detailed above grown on MS medium containing both 0.5% GABA
and 0.5% glutamic acid as the nitrogen source.
(F) The DABA AT and GabT reactions.
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targeting exopolysaccharide. This idea was based on their
observation that the residual pellicles of wild-type cells that
developed in the presence of norspermidine resembled the
wispy fragments of floating material seen for a mutant blocked
in exopolysaccharide production. However, in Figure S2B of
Kolodkin-Gal et al. (2012), the provision of 25 mMexogenous nor-
spermidine in the growth medium appears to have significantly
reduced the amount of residual wispy pellicle material in the
exopolysaccharide mutant, a result not commented upon by
the authors. We found that the wispy floating fragments of the
exopolysaccharide mutant did not develop when grown in con-
centrations of norspermidine that fully inhibited pellicle formation
in the wild-type strain (Figure 3B). When B. subtilis NCIB3610
wild-type cells were grown planktonically by Kolodkin-Gal
et al. (2012) (see Figure S4 in this reference) in liquid MSgg
with exogenous norspermidine present at a concentration
4-fold above the minimum inhibitory concentration (MIC) for
pellicle formation determined by the authors (4 3 25 mM), they
observed no inhibition of growth. In contrast, when we grew
planktonic wild-type cells in a concentration of norspermidine
4-fold above our observed MIC for pellicle formation (4 3
250 mM), planktonic growth was abolished for both wild-type
(Figure 3C) and exopolysaccharide mutant (Figure 3D) cells.
We found that planktonic growth of both wild-type and exopoly-
saccharide mutant cells is equally sensitive to lower concentra-
tions of exogenous norspermidine (Figures 3A and 3B). The
in vitro effects of norspermidine on the hydrodynamic radii of
exopolysaccharide reported by Kolodkin-Gal et al. (2012) (see
Figure 4 in this reference) were observed using 0.75mMnorsper-
midine, a concentration 30-fold higher than their reported MIC
for biofilm development. Our results indicate that exogenous
norspermidine does not act through the targeting of exopolysac-
charide; instead, norspermidine inhibits growth per se, which is
likely to be the predominant inhibitory factor preventing pellicle
development.
In conclusion, we find that B. subtilis NCIB3610 does not
encode orthologs of the V. cholerae norspermidine biosynthetic
pathway. Pellicle biofilms of B. subtilis do not contain natively
produced norspermidine at any stage of development, and
exogenous norspermidine is not inhibitory to pellicle develop-
ment until a concentration 10-fold higher than reported by
Kolodkin-Gal et al. (2012). We find that exogenous norspermi-
dine inhibits planktonic growth and pellicle development in an
exopolysaccharide-independent manner. Our data demonstrate
that norspermidine is not a self-produced trigger for biofilm
disassembly in B. subtilis and reconfirm the essential role of
spermidine for formation of robust biofilms, a role that can be
replaced more effectively at the same concentration by the
nonnative polyamine norspermidine.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions
Strains of B. subtilis used in this study are described in Table S2. All E. coli and
B. subtilis strains were routinely grown in LB liquid medium (10 g NaCl, 5 g
yeast extract, and 10 g tryptone/l) or on solid medium plates containing
1.5% Select Agar (Invitrogen) at 37C. V. parahaemolyticus RIMD 2210633
(a kind gift of K. Orth, University of Texas Southwestern Medical Center) was
grown in modified LB medium (MLB; tryptone 10 g, yeast extract 5 g, and
Figure 7. YaaO Is Not a Homolog of CANSDC
Alignment (CLUSTALW) is shown for the amino acid sequences of the C. jejuni CANSDC (GenBank WP_002855819 for Cjej CASDC), B. halodurans CANSDC
(GenBank NP_244826) homolog (Bhal CASDC), V. cholerae CANSDC (GenBank NP_231262 for Vcho CANSDC), and the B. subtilis YaaO protein (GenBank
NP_387908 for BsubYaaO). Gaps in the sequence alignment are highlighted in gray, red highlights the identity within the CANSDC/CASDC family of proteins, blue
highlights the identity in all four sequences, and black highlights the identity in three out of four sequences regardless of family. See also Figure S1.
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NaCl 30 g in 1 liter) at 30C. For growth in polyamine-free liquid medium,
strains were grown in MSgg medium (5 mM potassium phosphate and
100 mM MOPS at pH 7.0 supplemented with 2 mM MgCl2, 700 mM CaCl2,
50 mM MnCl2, 50 mM FeCl3, 1 mM ZnCl2, 2 mM thiamine, 0.5% glycerol, and
0.5% glutamate) (Branda et al., 2001) or on solid MSgg plates (solidified with
1.5% Select Agar). When appropriate, antibiotics were used at the following
concentrations: 100 mg/ml ampicillin, 100 mg/ml spectinomycin, 12.5 mg/ml
tetracycline, 0.5 mg/ml erythromycin, and 12.5 mg/ml lincomycin. Spermidine
and sym-norspermidine were obtained from Sigma-Aldrich, and sym-homo-
spermidine was a kind gift from Patrick Woster (Medical University of South
Carolina).
Strain Construction
All B. subtilis strains, plasmids, and primers used and constructed in this study
are listed in Tables S2, S3, and S4. For the construction and maintenance of
plasmids, E. coli strain MC1061 (F’lacIQ lacZM15 Tn10 (tet)) was used. Deriv-
atives of B. subtilis 168 were generated by transformation of competent cells
with plasmids using standard protocols of Harwood and Cutting (1990). For
introduction of DNA into B. subtilis strain NCIB3610, SPP1 phage transduc-
tions were conducted as described previously by Verhamme et al. (2007).
Strains containing in-frame gene deletions of speD and gabT were con-
structed using a modified version of a previously published method (Kiley
and Stanley-Wall, 2010). The upstream region of speD was PCR amplified
with primers NSW1500 and NSW1501, and the downstream region with
1502 and 1503. The two purified products were linked by further PCR using
the external primers 1500 and 1503. This product was cut with BamHI and Hin-
dIII and ligated into pUC19 cut with the same restriction enzymes, creating the
vector pNW1106, and the insert was then released by digestion with BamHI
and BglII and ligated into pMAD, creating vector pNW1111. The construct
for deletion of gabTwas created in a similar way: upstream DNAwas amplified
with NSW1508 andNSW1509 and downstreamwith NSW1510 andNSW1511;
the two products were then joined by PCR. Purified PCR product was cut with
XmaI and HindIII and ligated into pUC19, creating pNW1107, and the insert
was then released with XmaI and BglII and ligated into pMAD, creating
the vector pNW1110. Strains NRS4005 (NCIB3610 DspeD) and NRS4007
(NCIB3610 DgabT) were created by integration and curing of pNW1111 and
pNW1110, respectively, in NCIB 3610 as previously described (Kiley and
Stanley-Wall, 2010).
To introduce gabT under the control of the IPTG-inducible Phy-spank
promoter at the nonessential amyE locus, the coding region of gabT with its
ribosome-binding site was amplified from NCIB3610 genomic DNA with the
primers NSW1524 and NSW1525. The purified product was cut with HindIII
and SphI, then ligated into pDR111 cut with the same enzymes, creating the
vector pNW1114.
Colony and Pellicle Biofilm Formation
Strains of B. subtilis were grown overnight on MSgg plates at 37C. Single
colonies were inoculated into 3 ml MSgg and grown with shaking at 37C for
6 hr. To set up complex colonies, 10 ml of cells was spotted on MSgg plates
and incubated for 48 hr at 30C before imaging. For pellicle analysis, pellicles
were formed in either 2 or 10 ml of MSgg broth (with 2 or 10 ml of cells as inoc-
ulum, respectively) and were grown at 25C for the stated length of time.
Planktonic Growth Analysis
B. subtilis strains were streaked out to single colonies on an MSgg plate
and grown overnight at 37C. Single colonies were inoculated into 25 ml of
MSgg broth and grown overnight at 37C with shaking. Cells were diluted to
an optical density at 600 nm (OD600nm) of 0.01 in 25 ml of fresh MSgg broth
and incubated at 37C with shaking at 200 rpm. Polyamines were added to
the growth media at the final concentrations indicated immediately prior to
inoculation. Planktonic growth was measured by OD600nm readings.
Growth on 4-Aminobutyric Acid as Sole Nitrogen Source
Strains ofB. subtiliswere streaked out to single colonies on anMSgg plate and
grown overnight at 37C. Single colonies were then streaked onto MS plates
(5 mM potassium phosphate and 100 mM MOPS at pH 7.0 supplemented
with 2 mM MgCl2, 700 mM CaCl2, 50 mM MnCl2, 50 mM FeCl3, 1 mM ZnCl2,
and 2 mM thiamine) with 0.5% glycerol as a carbon source, and with either
0.5% glutamic acid or 0.5% 4-aminobutyric acid (GABA) or both as a nitrogen
source. For induction of the gabT-complemented strain, 50 mM IPTG was
added to the growth medium. Plates were grown again at 37C overnight
before being imaged.
Preparation of PellicleMaterial for Derivatization of Polyamineswith
AccQ-Fluor Reagent
Pellicles of B. subtilis NCIB3610 and derivative strains were grown in 10 ml
of liquid MSgg in 6-well plates (Greiner Bio-One). The 10 ml of pellicle mate-
rial and spent medium was transferred to a 15 ml Falcon tube and centri-
fuged to pellet the pellicle material including both cells and matrix. The pellet
was resuspended with 0.25 ml H20, and then 40% trichloroacetic acid was
added to a final concentration of 10% and incubated on ice for 30 min.
This pellicle suspension was subjected to three cycles of freeze/thawing.
After centrifugation (18,000 3 g, 5 min, 4C), the resulting supernatant was
used for immediate analysis or stored at 20C until needed. The 1,7-diami-
noheptane internal standard and pure polyamine standards were added
to the pellicles immediately before extraction of the pellicle material by tri-
chloroacetic acid.
Derivatization of Samples with AccQ-Fluor Reagent and HPLC
Analysis
Analysis of trichloroacetic acid-extracted polyamines was performed by pre-
column derivatization with AccQ-Fluor reagent labeling kit (Waters; catalog
No. WAT052880). For each sample (5 ml), derivatization was carried out in a
total volume of 100 ml AccQ-fluor borate buffer and heated to 55C for
10 min. Polyamines labeled with the AccQ-Fluor reagent were separated by
HPLC with a hydrolysate amino acid analysis column (AccQ-Tag column,
60 A˚, 4 mm, 3.9 3 150 mm; Waters) on a Beckman Coulter System Gold
with fluorescence detection (excitation, 248 nm; emission, 398 nm [Prostar]).
The solvent system consisted of solvent A (520 mM sodium acetic acid,
17 mM triethylamine, and 0.01% sodium azide [pH 4.65]) and solvent B
(60% acetonitrile, 0.01% acetone at a flow rate of 1.0 ml/min). Elution was
performed using a linear gradient of buffer B: 2–6 min, 0%–20%; 6–11 min,
20%; 11–27 min, 20%–50%; 27–34 min, 50%; 34–37 min, 100%; and
40–50 min, 0%.
Calculation of the Limit of Detection of Norspermidine in Pellicle
Material
Eight-day-old pellicle material grown in 10ml of MSggmedium in 6-well plates
was centrifuged and resuspended in H2O to a volume of 350 ml. One of several
norspermidine stock solutions of different concentrations was added (9.6 ml),
along with 15 ml of 3 mM 1,7-diaminoheptane to the resuspended pellicle ma-
terial, which included cells and pellicle matrix, mixed and then extracted with
117 ml of trichloroacetic acid and made up to a final volume of 500 ml. The
apparent concentration of the norspermidine spike in the sample was taken
as the concentration of norspermidine in the 500 ml final volume of extracted
pellicle suspension. After three cycles of freeze/thawing, the suspension
was centrifuged and then 5 ml of the supernatant was added to 75 ml of borate
buffer and 20 ml of AccQ-Fluor reagent. After the labeling reaction, 20 ml of this
was used for HPLC analysis.
Pellicle Biofilm Sample Preparation for HPLC Analysis
Pellicles formed in 10 ml of liquid MSgg were set up as described above.
Samples were taken for analysis at various days after inoculation. The pellicle
material and liquidmedia were both transferred to a centrifuge tube and centri-
fuged at 4,000 3 g for 10 min. The pellet representing all pellicular material,
both cells and biofilm matrix were analyzed by HPLC as described below.
Preparation of Pellicle Material for Dansylation of Polyamines
Pellicles formed in 10ml of liquid MSgg were set up as described above. Sam-
ples were taken for analysis at various days after inoculation. The pellicle ma-
terial and liquid medium were both transferred to a 15 ml Falcon tube and
centrifuged at 3,750 rpm for 10min. Supernatant was removed, and the pellicle
pellet was resuspended in 0.25ml H2O for 1-day and 8-day pellicles and 0.5ml
for 3-day pellicles. After resuspension, 15 ml of 0.4 mM 1,7-diaminoheptane
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(the internal standard) was added to the samples before addition of the
trichloroacetic acid. An equal volume (to the H2O used for resuspension) of tri-
chloroacetic acid (made in 10 mMHCl) was added to the resuspended pellicle
samples. The solution was kept on ice for 30 min to precipitate protein, which
was pelleted by centrifugation, and the supernatant was transferred to another
tube. This supernatant was extracted five times with water-saturated ethyl
acetate (polyamines remain in the bottom layer; the top layer was discarded).
The liquid was removed by freeze-drying overnight, and the solid material was
reconstituted with 50 ml 10 mM HCl.
Derivatization of Samples with Dansyl Chloride and HPLC Analysis
Fresh dansyl chloride (5-dimethylaminonapthalene-1-sulphonyl chloride) solu-
tion was prepared as 10 mg/ml in redistilled acetone, wrapped in foil, and kept
on ice (Kabra et al., 1986). A total of 200 ml saturated Na2CO3 (pH rises to
approximately 10) and 200 ml of dansyl chloride solution was added to 50 ml
of the pellicle sample. After mixing, the solution was heated to 70C for
10 min, cooled to room temperature, and then 100 ml 25% (w/v) L-proline
was added to mop up excess dansyl chloride. The top acetone layer was
retained for HPLC analysis using ion-paired reverse-phase HPLC on an Ultra-
sphere C18 column using a Dionex Ultimate 3000 instrument fitted with a
Dionex RF-2000 fluorometer (set at 340 nm excitation and 515 nm emission).
The solvent system consisted of solvent A (10 mM sodium phosphate mono-
basic phosphate buffer [NaH2PO4.H2O] [pH 4.2]) and solvent B (acetonitrile).
Elution was performed at a flow rate of 2.0 ml/min, the column equilibrated
in 40% solvent B for 8 min, then a linear gradient of solvent B: 0–25 min,
40%–65%; 25–35 min, 65%–90%; and 35–42 min, 90%. See the Extended
Experimental Procedures for more information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
tables, and one figure and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2014.01.012.
AUTHOR CONTRIBUTIONS
Experiments were designed, performed, and analyzed by N.R.S.-W., A.H.F.,
L.H., S.W., S.H.K., Y.M., and A.J.M. L.H. and N.R.S.-W. constructed strains,
and L.H., N.R.S.-W., and Y.M. performed biofilm and cell growth assays.
S.H.K., S.W., and A.H.F. optimized and performed polyamine analysis on sam-
ples prepared by L.H. and S.H.K. L.H. prepared samples for whole-genome
SNP analysis. SNP identification was by L.H. and N.R.S.-W. with further bioin-
formatics analysis by N.R.S.-W., A.H.F., and A.J.M. The paper was written and
edited by A.J.M., A.H.F., N.R.S.-W., and L.H.
ACKNOWLEDGMENTS
We thank David Mangelsdorf for helpful discussions and http://www.
sarahjcgillespie.com for design work on the graphical abstract. This work
was supported by grant BB/I019464/1 from the Biotechnology and Biological
Sciences Research Council, UK (to N.R.S.-W.), by grant 079838 from theWell-
come Trust (to A.H.F.), and by a High Impact/High Risk Award from UT South-
western Medical Center (to A.J.M.). Genome sequencing and analysis were
performed at the Genomic Sequencing Unit, University of Dundee, which is
funded by the Wellcome Trust Strategic Grant (098439/Z/12/(Z)). We thank
Prof. Richard Losick for providing strain NCIB3610-H.
Received: October 16, 2013
Revised: December 19, 2013
Accepted: January 7, 2014
Published: February 13, 2014
REFERENCES
Belitsky, B.R., and Sonenshein, A.L. (2002). GabR, amember of a novel protein
family, regulates the utilization of gamma-aminobutyrate in Bacillus subtilis.
Mol. Microbiol. 45, 569–583.
Branda, S.S., Gonza´lez-Pastor, J.E., Ben-Yehuda, S., Losick, R., and Kolter,
R. (2001). Fruiting body formation by Bacillus subtilis. Proc. Natl. Acad. Sci.
USA 98, 11621–11626.
Branda, S.S., Vik, S., Friedman, L., and Kolter, R. (2005). Biofilms: the matrix
revisited. Trends Microbiol. 13, 20–26.
Branda, S.S., Chu, F., Kearns, D.B., Losick, R., and Kolter, R. (2006). A major
protein component of the Bacillus subtilis biofilm matrix. Mol. Microbiol. 59,
1229–1238.
Burrell, M., Hanfrey, C.C., Murray, E.J., Stanley-Wall, N.R., and Michael, A.J.
(2010). Evolution and multiplicity of arginine decarboxylases in polyamine
biosynthesis and essential role in Bacillus subtilis biofilm formation. J. Biol.
Chem. 285, 39224–39238.
Costerton, J.W., Lewandowski, Z., Caldwell, D.E., Korber, D.R., and Lappin-
Scott, H.M. (1995). Microbial biofilms. Annu. Rev. Microbiol. 49, 711–745.
Davey, M.E., and O’Toole, G.A. (2000). Microbial biofilms: from ecology to
molecular genetics. Microbiol. Mol. Biol. Rev. 64, 847–867.
Deng, X., Lee, J., Michael, A.J., Tomchick, D.R., Goldsmith, E.J., and Phillips,
M.A. (2010). Evolution of substrate specificity within a diverse family of beta/
alpha-barrel-fold basic amino acid decarboxylases: X-ray structure determi-
nation of enzymes with specificity for L-arginine and carboxynorspermidine.
J. Biol. Chem. 285, 25708–25719.
Dover, S., and Halpern, Y.S. (1974). Genetic analysis of the gamma-aminobu-
tyrate utilization pathway in Escherichia coli K-12. J. Bacteriol. 117, 494–501.
Flemming, H.C., andWingender, J. (2010). The biofilmmatrix. Nat. Rev. Micro-
biol. 8, 623–633.
Gardan, R., Rapoport, G., and De´barbouille´, M. (1995). Expression of the
rocDEF operon involved in arginine catabolism in Bacillus subtilis. J. Mol.
Biol. 249, 843–856.
Harwood, C.R., and Cutting, S.M. (1990). Molecular Biological Methods for
Bacillus (Chichester: John Wiley & Sons).
Hobley, L., Ostrowski, A., Rao, F.V., Bromley, K.M., Porter, M., Prescott, A.R.,
MacPhee, C.E., van Aalten, D.M., and Stanley-Wall, N.R. (2013). BslA is a self-
assembling bacterial hydrophobin that coats the Bacillus subtilis biofilm. Proc.
Natl. Acad. Sci. USA 110, 13600–13605.
Ikai, H., and Yamamoto, S. (1994). Cloning and expression in Escherichia coli
of the gene encoding a novel L-2,4-diaminobutyrate decarboxylase of
Acinetobacter baumannii. FEMS Microbiol. Lett. 124, 225–228.
Ikai, H., and Yamamoto, S. (1997). Identification and analysis of a gene
encoding L-2,4-diaminobutyrate:2-ketoglutarate 4-aminotransferase involved
in the 1,3-diaminopropane production pathway in Acinetobacter baumannii.
J. Bacteriol. 179, 5118–5125.
Joo, H.S., and Otto, M. (2012). Molecular basis of in vivo biofilm formation by
bacterial pathogens. Chem. Biol. 19, 1503–1513.
Kabra, P.M., Lee, H.K., Lubich, W.P., and Marton, L.J. (1986). Solid-phase
extraction and determination of dansyl derivatives of unconjugated and
acetylated polyamines by reversed-phase liquid chromatography: improved
separation systems for polyamines in cerebrospinal fluid, urine and tissue.
J. Chromatogr. A 380, 19–32.
Karatan, E., andMichael, A.J. (2013). A wider role for polyamines in biofilm for-
mation. Biotechnol. Lett. 35, 1715–1717.
Karatan, E., Duncan, T.R., and Watnick, P.I. (2005). NspS, a predicted poly-
amine sensor, mediates activation of Vibrio cholerae biofilm formation by nor-
spermidine. J. Bacteriol. 187, 7434–7443.
Kiley, T.B., and Stanley-Wall, N.R. (2010). Post-translational control of Bacillus
subtilis biofilm formation mediated by tyrosine phosphorylation. Mol. Micro-
biol. 78, 947–963.
Kobayashi, K., and Iwano, M. (2012). BslA(YuaB) forms a hydrophobic layer on
the surface of Bacillus subtilis biofilms. Mol. Microbiol. 85, 51–66.
Kolodkin-Gal, I., Cao, S., Chai, L., Bo¨ttcher, T., Kolter, R., Clardy, J., and
Losick, R. (2012). A self-produced trigger for biofilm disassembly that targets
exopolysaccharide. Cell 149, 684–692.
Cell 156, 844–854, February 13, 2014 ª2014 The Authors 853
Konkol, M.A., Blair, K.M., and Kearns, D.B. (2013). Plasmid-encoded ComI in-
hibits competence in the ancestral 3610 strain of Bacillus subtilis. J. Bacteriol.
195, 4085–4093.
Lee, J., Sperandio, V., Frantz, D.E., Longgood, J., Camilli, A., Phillips, M.A.,
and Michael, A.J. (2009). An alternative polyamine biosynthetic pathway is
widespread in bacteria and essential for biofilm formation in Vibrio cholerae.
J. Biol. Chem. 284, 9899–9907.
McGinnis, M.W., Parker, Z.M., Walter, N.E., Rutkovsky, A.C., Cartaya-Marin,
C., and Karatan, E. (2009). Spermidine regulates Vibrio cholerae biofilm forma-
tion via transport and signaling pathways. FEMSMicrobiol. Lett. 299, 166–174.
Mountain, A., McChesney, J., Smith, M.C., and Baumberg, S. (1986). Gene
sequence encoding early enzymes of arginine synthesis within a cluster in
Bacillus subtilis, as revealed by cloning in Escherichia coli. J. Bacteriol. 165,
1026–1028.
Nakao, H., Shinoda, S., and Yamamoto, S. (1991). Purification and some prop-
erties of carboxynorspermidine synthase participating in a novel biosynthetic
pathway for norspermidine in Vibrio alginolyticus. J. Gen. Microbiol. 137,
1737–1742.
Ostrowski, A., Mehert, A., Prescott, A., Kiley, T.B., and Stanley-Wall, N.R.
(2011). YuaB functions synergistically with the exopolysaccharide and TasA
amyloid fibers to allow biofilm formation by Bacillus subtilis. J. Bacteriol.
193, 4821–4831.
Patel, C.N., Wortham, B.W., Lines, J.L., Fetherston, J.D., Perry, R.D., and
Oliveira, M.A. (2006). Polyamines are essential for the formation of plague
biofilm. J. Bacteriol. 188, 2355–2363.
Romero, D., Aguilar, C., Losick, R., and Kolter, R. (2010). Amyloid fibers
provide structural integrity to Bacillus subtilis biofilms. Proc. Natl. Acad. Sci.
USA 107, 2230–2234.
Schneider, G., Ka¨ck, H., and Lindqvist, Y. (2000). The manifold of vitamin B6
dependent enzymes. Structure 8, R1–R6.
Sekowska, A., Bertin, P., and Danchin, A. (1998). Characterization of poly-
amine synthesis pathway in Bacillus subtilis 168. Mol. Microbiol. 29, 851–858.
Sekowska, A., Coppe´e, J.Y., Le Caer, J.P., Martin-Verstraete, I., and Danchin,
A. (2000). S-adenosylmethionine decarboxylase of Bacillus subtilis is closely
related to archaebacterial counterparts. Mol. Microbiol. 36, 1135–1147.
Srivatsan, A., Han, Y., Peng, J., Tehranchi, A.K., Gibbs, R., Wang, J.D., and
Chen, R. (2008). High-precision, whole-genome sequencing of laboratory
strains facilitates genetic studies. PLoS Genet. 4, e1000139.
Verhamme, D.T., Kiley, T.B., and Stanley-Wall, N.R. (2007). DegU co-ordinates
multicellular behaviour exhibited by Bacillus subtilis. Mol. Microbiol. 65,
554–568.
Vlamakis, H., Chai, Y., Beauregard, P., Losick, R., and Kolter, R. (2013). Stick-
ing together: building a biofilm the Bacillus subtilis way. Nat. Rev. Microbiol.
11, 157–168.
Wortham, B.W., Oliveira, M.A., Fetherston, J.D., and Perry, R.D. (2010). Poly-
amines are required for the expression of key Hms proteins important for
Yersinia pestis biofilm formation. Environ. Microbiol. 12, 2034–2047.
Yamamoto, S., Hamanaka, K., Suemoto, Y., Ono, B., and Shinoda, S. (1986).
Evidence for the presence of a novel biosynthetic pathway for norspermidine in
Vibrio. Can. J. Microbiol. 32, 99–103.
854 Cell 156, 844–854, February 13, 2014 ª2014 The Authors
